Navigation Links
Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps
Date:7/13/2009

ALISO VIEJO, Calif., July 13 /PRNewswire/ -- Bausch & Lomb announced today that it has received approval from the Food and Drug Administration (FDA) to market the Crystalens HD(TM) in quarter diopter steps in the United States. The Crystalens accommodating intraocular lens (IOL) was first approved by the FDA in November 2003. Bausch & Lomb made the announcement today in conjunction with the celebration of the Crystalens HD first anniversary of approval. The Crystalens HD is the fourth generation of the only FDA approved accommodating lens and is the number one selling presbyopic channel lens in the U.S.

The surface of the Crystalens HD has been shaped to enhance the depth of focus with an optical modification. The enhanced optic provides an increased depth of focus which is designed to improve near vision without compromising intermediate or distance vision.

Dr. John Hovanesian was a principal investigator in the FDA study. He serves as clinical instructor at the Jules Stein Eye Institute, UCLA, in California and is in private practice at Harvard Eye Associates in Laguna Hills, California. "If I were a patient having cataract surgery, I would want an IOL that projects 100% of available light to a single point of focus in the eye, and also provides a broad range of distance, intermediate and near vision. The Crystalens HD is the best available lens to achieve that goal," said Dr. Hovanesian. "There is no question that the HD is my lens of choice for presbyopia correction in patients with cataracts. The addition of quarter diopters will only enhance my ability to target and provide patients the best possible outcomes with the Crystalens HD."

Quarter diopters will be available for the Crystalens HD for the models HD500 and HD520 in the ranges of 18-22. Bausch & Lomb expects to have the diopters available in a wi
'/>"/>

SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
2. Bausch & Lombs Crystalens to be Featured in Florida Advertising Campaign.
3. Bausch & Lomb Survey Shows People with Astigmatism Unaware of Contact Lens Options
4. Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development
5. Bausch & Lomb Launches Multi-Tiered U.S. Consumer Education Initiative to Raise Awareness of Presbyopia
6. Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide See a New You
7. VIDEO from Medialink and Bausch & Lomb: Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide See a New You
8. Bausch & Lomb Japan Names Mitsuo Hirose as Chairman
9. Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture
10. Bausch & Lomb Appoints Global Vision Care and North American Vision Care Presidents
11. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Wellesley, Mass., (PRWEB) September 01, 2014 ... report, BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS ... reached $21.8 million in 2013 and is expected to ... further grow to $471.5 million by 2019, which is ... 2014 through 2019. The receptor-mediated transport (RMT) segment is ...
(Date:9/1/2014)... 2014 Parties involved in federally-filed Tylenol ... litigation’s status conference in September, where issues related to ... the Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. ... posted on the Court’s website, the meeting is scheduled ... a.m. This is the latest of several Tylenol conferences ...
(Date:9/1/2014)... Ontraport , one of the latest ... to automate the small intricacies of managing an online ... prompting an investigative review. , “As a new ... all of the small details involved with running a ... “That’s why Ontraport has become so popular in this ...
(Date:9/1/2014)... AttorneyOne.com, a recognized authority on law, update ... the FDA on DePuy Synthes Craniomaxillofacial Distraction System ... 28, that specific lots of DePuy Synthes Craniomaxillofacial Distraction ... device may reverse directions after surgery. According to ... is an implant used to lengthen and/or stabilize the ...
(Date:9/1/2014)... 01, 2014 Beginning Tuesday, September 2nd, ... medical professionals and 10,000 consumers for the annual gathering ... gathering of the nation’s top medical professionals who specializes ... conditions. The week-long event contains more than 120 hours ... available in the pain management field. , MarijuanaDoctors.com is ...
Breaking Medicine News(10 mins):Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2
... the largest study of its kind for the genetic roots ... Disease as well as further evidence that some people of ... study examined changes in DNA associated with the two most ... which is most frequently marked by inflammation of the final ...
... Assessment Tools To ... Healthier Lifestyles, NEW YORK, March 26 EnergyNow!, ... and fitness,technology fields, today announced the availability of a ... Delaware, Maryland,Pennsylvania, Virginia, West Virginia and Washington D.C. combat ...
... Governor Edward G.,Rendell today announced the state,s new ... ahead to better meet their future,long-term care needs., ... be put off. If,people do fail to prepare, it ... "The ,Own Your Future, campaign,empowers consumers to take steps ...
... Award-Winning Mind Fitness Company, WASHINGTON, March 26 ... Ltd., the company that uses the latest scientific,research ... cognitive,performance and health, today announced that it will ... the American Society on Aging,(ASA), as a consultant., ...
... Technologies(R),Inc. ("Global Med" or the "Company") (OTC Bulletin ... announced,the sale yesterday, March 25, 2008, of approximately ... was held by SingXpress Ltd., an Asian company,(previously ... were sold,to five American institutions and the transaction ...
... lower health-related quality of life for their children ... from the parents of healthy children. However, reports ... These findings are published in the April issue ... online at Wiley Interscience (www.interscience.wiley.com ). , Children ...
Cached Medicine News:Health News:Large multicenter study suggests new genetic markers for Crohn's disease 2Health News:EnergyNow! Announces New Grant Funding to Combat Childhood Obesity 2Health News:EnergyNow! Announces New Grant Funding to Combat Childhood Obesity 3Health News:Governor Rendell Announces 'Own Your Future' Campaign; Urges Consumers to Better Plan Their Long-Term Care Needs 2Health News:CogniFit to Work With Gloria Cavanaugh, Former ASA President 2Health News:Global Med Technologies(R), Inc. Announces the Sale of Approximately 3.3 Million Shares of Global Med Common Stock Held by SingXpress Ltd., an Asian Company, to Five American Institutions 2Health News:Study shows lifetime effects of pediatric liver transplants 2
(Date:9/1/2014)... Reportlinker.com announces that ... its catalogue: Antibody Drug Conjugates Market ... http://www.reportlinker.com/p02280919/Antibody-Drug-Conjugates-Market-2nd-Edition-2014---2024.html INTRODUCTION Antibody ... therapeutic agents, gaining increasing attention from both large ... marriage of an antibody with a toxic drug ...
(Date:8/30/2014)...   Royal Philips  (NYSE: PHG, AEX: PHIA) today ... ultrasound system designed to enable global hospitals and health ... and cost pressures. Making its debut at the  European ... Barcelona this week, Affiniti provides innovative technology ... resources deliver high quality patient care. ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM ... (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that ... recall to address a potential issue with a ... for the Axilla application of the SAM Junctional ...
Breaking Medicine Technology:Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 2Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 3Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 4Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 5Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 6Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 7Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 8Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 10Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 11Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 12Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 13Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 14Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 15Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 16Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 17Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 18Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2
... , TUCSON, Ariz. , Feb. 4 ... care. Arizona Oncology physicians will now treat patients at Marana Healthcare Clinic ... medical oncologists, are now actively caring for patients at MHC. , "We ... "By providing cancer care services in Marana we are able ...
... , SUNNYVALE, Calif. , Feb. 4 ... of radiosurgery, announced today financial results for the second quarter of fiscal ... second quarter of fiscal 2010, Accuray reported total revenue of $57.3 ... of $57.6 million . , Accuray reported a net loss ...
Cached Medicine Technology:Cancer Patients in Marana Now Have Local Access to Advanced Cancer Care 2Cancer Patients in Marana Now Have Local Access to Advanced Cancer Care 3Cancer Patients in Marana Now Have Local Access to Advanced Cancer Care 4Accuray Announces Results for Second Quarter Fiscal 2010 2Accuray Announces Results for Second Quarter Fiscal 2010 3Accuray Announces Results for Second Quarter Fiscal 2010 4Accuray Announces Results for Second Quarter Fiscal 2010 5Accuray Announces Results for Second Quarter Fiscal 2010 6Accuray Announces Results for Second Quarter Fiscal 2010 7Accuray Announces Results for Second Quarter Fiscal 2010 8Accuray Announces Results for Second Quarter Fiscal 2010 9Accuray Announces Results for Second Quarter Fiscal 2010 10Accuray Announces Results for Second Quarter Fiscal 2010 11Accuray Announces Results for Second Quarter Fiscal 2010 12
... Lyphochek Immunoassay Plus Control provides ... comprehensive control in the world for ... procedures, eliminating the need for separate ... no added preservatives, it is suitable ...
... Plus Control is a liquid ... today's busy immunoassay laboratory. With ... human serum based control can ... control products for immunoassay and ...
Liquichek Immunology Control is a trilevel, liquid, comprehensive serum protein control with assayed values for a wide number of methods....
... Detection Platform provides fully automated detection of ... platform for molecular pathology labs separates DNA ... features that deliver a high degree of ... the capacity to run two 96-well plates, ...
Medicine Products: